
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Remove Australian Register of Therapeutic Goods (ARTG) filter Australian Register of Therapeutic Goods (ARTG) (1)
- Biologicals (2) Apply Biologicals filter
- Remove Complementary medicines filter Complementary medicines (7)
- Remove Disinfectants/Sterilants filter Disinfectants/Sterilants (0)
- Fees/Payments (1) Apply Fees/Payments filter
- Remove Import/Export filter Import/Export (1)
- Remove Labelling/Packaging filter Labelling/Packaging (1)
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Medical devices/IVDs (55) Apply Medical devices/IVDs filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (5) Apply Prescription medicines filter
- Remove Safety of medicines & medical devices filter Safety of medicines & medical devices (0)
- Scheduling (55) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Australian Register of Therapeutic Goods (ARTG) filter Australian Register of Therapeutic Goods (ARTG)
- (-) Remove Disinfectants/Sterilants filter Disinfectants/Sterilants
- (-) Remove Labelling/Packaging filter Labelling/Packaging
- (-) Remove Complementary medicines filter Complementary medicines
- (-) Remove Import/Export filter Import/Export
- (-) Remove Safety of medicines & medical devices filter Safety of medicines & medical devices
Proposed update to the evidence guidelines for listed medicines
Closed on 1 April 2022
Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Methyl salicylate
Closed on 18 May 2021
Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Lidocaine (lignocaine)
Closed on 18 May 2021
Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Sedating antihistamines
Closed on 18 May 2021
Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Menthol
Closed on 18 May 2021
Proposal to remove redundant processes for entering certain formulation information into a therapeutic goods application
Closed on 24 February 2021
Export of therapeutic goods from Australia
Closed on 3 February 2020
Discontinuing pre-market evaluation of Herbal Component Names (HCNs)
Closed on 12 January 2018
Public access to information contained in ARTG entries for therapeutic goods
Closed on 3 February 2006
Labelling project 99/00 Effective by design
Closed on 23 June 2000